The College of Medicine’s Institute for Personalized Medicine Biobank received accreditation for its exceptional storage, tracking and maintenance of samples from a national organization renowned for their quality assurance standards.
The biorepository at the Institute for Personalized Medicine joins more than 8,000 facilities worldwide to be accredited by the College of American Pathologists, the world’s largest body of board-certified pathologists who advocate for high-quality and cost-effective medical care. The accreditation program began in 2012 with the goal of providing requirements for the standardization of processes that will result in high-quality human specimens and genetic materials that can be used to support research.
The biorepository currently holds more than 120,000 samples from Penn State Health Milton S. Hershey Medical Center patients who provide consent when visiting a clinic or in preparation for surgery. They are used for a variety of research studies and include a collection of specimens from patients diagnosed with COVID-19.
In addition to COVID-19 research, the Institute for Personalized Medicine supports studies for various cancers, neurodegenerative diseases, orthopedic conditions, psychiatric disorders, and other diseases.
Click here to read more.